https://ih.advfn.com/stock-market/USOTC/generex-bi
Post# of 36519
![](/assets/46931549/no_avatar_available_thumb.jpg)
Generex Biotechnology (GNBT) is a OTC biotech worth some attention. GNBT is a Phoenix strategy rising from the ashes of a NASDAQ crash. The company is loaded with proven IP and big pharma relationships. With the SPAC buzz bringing attention to the Biotech market, GNBT could deliver big returns at any moment.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)